This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Alberta directory, so their courses and email address may be missing. Find their university profile.
Latest papers
Milrinone is preferred to levosimendan for mesenteric perfusion in hypoxia-reoxygenated newborn piglets treated with dopamine.
Pediatric research · 2012
Latest funding
- $2,222,325
Does the use of higher versus lower oxygen concentration improve neurodevelopmental outcomes at 18-24 months in very low birthweight infants? - The HiLo-Trial
CIHR · 2019 · Principal investigator
1 publications.
Milrinone is preferred to levosimendan for mesenteric perfusion in hypoxia-reoxygenated newborn piglets treated with dopamine.
Manouchehri N, Bigam DL, Churchill T, Joynt C, Vento M, Cheung PY
Does the use of higher versus lower oxygen concentration improve neurodevelopmental outcomes at 18-24 months in very low birthweight infants? - The HiLo-Trial
Principal investigators: Schmoelzer, Georg; Asztalos, Elizabeth V; Shah, Prakeshkumar; Tarnow-Mordi, William; Vento, Maximo
Keywords: Clinical Trial; Delivery Room; Neonatal Resuscitation; Preterm Infants
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.